DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness

Peir In Liang, Bi Wen Yeh, Wei Ming Li, Ti Chun Chan, I. Wei Chang, Chun Nung Huang, Ching Chia Li, Hung Lung Ke, Hsin Chih Yeh, Wen Jeng Wu, Chien Feng Li

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Urothelial carcinoma (UC) is common cancer worldwide. The molecular aberrations regarding tumor progression remain unclear. Pericellular proteolysis is crucial in tumorigenesis, but its significance is unexplored in UC. By data mining the datasets in Gene Expression Omnibus, specifically focus on the proteolysis pathway, and followed by a preliminary validation in a pilot batch of tumor samples, we identified that the upregulation of dipeptidyl peptidase 4 (DPP4) was most significantly associated with clinical aggressiveness of UCs. Quantitative RT-PCR confirmed upregulation of DPP4 mRNA in advanced stage UCs. The clinical significance of DPP4 expression was validated in our large cohort consists of 635 UCs from upper urinary tract and urinary bladder. Univariate and multivariate analyses show that DPP4 is an independent prognosticatory biomarker for disease-specific survival and metastasis-free survival. Comparing the DPP4 expression level of three urothelial cell lines with normal urothelial cells, J82 and RTCC-1 showed a significantly increased in transcript and protein expression. DPP4 knockdown as conducted by using short-hairpin RNA resulted in a significantly decreased cell viability, proliferation, migration, and invasion in J82 and RTCC-1 cells. These findings implicate that DPP4 plays a role in the aggressiveness of UCs, and can serve as a novel prognostic marker and therapeutic target.

Original languageEnglish
Pages (from-to)2995-3008
Number of pages14
JournalOncotarget
Volume8
Issue number2
DOIs
Publication statusPublished - Jan 1 2017
Externally publishedYes

Fingerprint

Dipeptidyl Peptidase 4
Carcinoma
Proteolysis
Up-Regulation
Neoplasms
Data Mining
Urinary Tract
Small Interfering RNA
Cell Survival
Carcinogenesis
Urinary Bladder
Multivariate Analysis
Biomarkers
Cell Proliferation
Neoplasm Metastasis
Gene Expression
Cell Line
Polymerase Chain Reaction
Messenger RNA

Keywords

  • DPP4
  • Overexpression
  • Proteolysis
  • Urothelial carcinoma

ASJC Scopus subject areas

  • Oncology

Cite this

DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness. / Liang, Peir In; Yeh, Bi Wen; Li, Wei Ming; Chan, Ti Chun; Chang, I. Wei; Huang, Chun Nung; Li, Ching Chia; Ke, Hung Lung; Yeh, Hsin Chih; Wu, Wen Jeng; Li, Chien Feng.

In: Oncotarget, Vol. 8, No. 2, 01.01.2017, p. 2995-3008.

Research output: Contribution to journalArticle

Liang, Peir In ; Yeh, Bi Wen ; Li, Wei Ming ; Chan, Ti Chun ; Chang, I. Wei ; Huang, Chun Nung ; Li, Ching Chia ; Ke, Hung Lung ; Yeh, Hsin Chih ; Wu, Wen Jeng ; Li, Chien Feng. / DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness. In: Oncotarget. 2017 ; Vol. 8, No. 2. pp. 2995-3008.
@article{27f07bb5c1eb4bb0b05821f9ceed8d20,
title = "DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness",
abstract = "Urothelial carcinoma (UC) is common cancer worldwide. The molecular aberrations regarding tumor progression remain unclear. Pericellular proteolysis is crucial in tumorigenesis, but its significance is unexplored in UC. By data mining the datasets in Gene Expression Omnibus, specifically focus on the proteolysis pathway, and followed by a preliminary validation in a pilot batch of tumor samples, we identified that the upregulation of dipeptidyl peptidase 4 (DPP4) was most significantly associated with clinical aggressiveness of UCs. Quantitative RT-PCR confirmed upregulation of DPP4 mRNA in advanced stage UCs. The clinical significance of DPP4 expression was validated in our large cohort consists of 635 UCs from upper urinary tract and urinary bladder. Univariate and multivariate analyses show that DPP4 is an independent prognosticatory biomarker for disease-specific survival and metastasis-free survival. Comparing the DPP4 expression level of three urothelial cell lines with normal urothelial cells, J82 and RTCC-1 showed a significantly increased in transcript and protein expression. DPP4 knockdown as conducted by using short-hairpin RNA resulted in a significantly decreased cell viability, proliferation, migration, and invasion in J82 and RTCC-1 cells. These findings implicate that DPP4 plays a role in the aggressiveness of UCs, and can serve as a novel prognostic marker and therapeutic target.",
keywords = "DPP4, Overexpression, Proteolysis, Urothelial carcinoma",
author = "Liang, {Peir In} and Yeh, {Bi Wen} and Li, {Wei Ming} and Chan, {Ti Chun} and Chang, {I. Wei} and Huang, {Chun Nung} and Li, {Ching Chia} and Ke, {Hung Lung} and Yeh, {Hsin Chih} and Wu, {Wen Jeng} and Li, {Chien Feng}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.13820",
language = "English",
volume = "8",
pages = "2995--3008",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "2",

}

TY - JOUR

T1 - DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness

AU - Liang, Peir In

AU - Yeh, Bi Wen

AU - Li, Wei Ming

AU - Chan, Ti Chun

AU - Chang, I. Wei

AU - Huang, Chun Nung

AU - Li, Ching Chia

AU - Ke, Hung Lung

AU - Yeh, Hsin Chih

AU - Wu, Wen Jeng

AU - Li, Chien Feng

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Urothelial carcinoma (UC) is common cancer worldwide. The molecular aberrations regarding tumor progression remain unclear. Pericellular proteolysis is crucial in tumorigenesis, but its significance is unexplored in UC. By data mining the datasets in Gene Expression Omnibus, specifically focus on the proteolysis pathway, and followed by a preliminary validation in a pilot batch of tumor samples, we identified that the upregulation of dipeptidyl peptidase 4 (DPP4) was most significantly associated with clinical aggressiveness of UCs. Quantitative RT-PCR confirmed upregulation of DPP4 mRNA in advanced stage UCs. The clinical significance of DPP4 expression was validated in our large cohort consists of 635 UCs from upper urinary tract and urinary bladder. Univariate and multivariate analyses show that DPP4 is an independent prognosticatory biomarker for disease-specific survival and metastasis-free survival. Comparing the DPP4 expression level of three urothelial cell lines with normal urothelial cells, J82 and RTCC-1 showed a significantly increased in transcript and protein expression. DPP4 knockdown as conducted by using short-hairpin RNA resulted in a significantly decreased cell viability, proliferation, migration, and invasion in J82 and RTCC-1 cells. These findings implicate that DPP4 plays a role in the aggressiveness of UCs, and can serve as a novel prognostic marker and therapeutic target.

AB - Urothelial carcinoma (UC) is common cancer worldwide. The molecular aberrations regarding tumor progression remain unclear. Pericellular proteolysis is crucial in tumorigenesis, but its significance is unexplored in UC. By data mining the datasets in Gene Expression Omnibus, specifically focus on the proteolysis pathway, and followed by a preliminary validation in a pilot batch of tumor samples, we identified that the upregulation of dipeptidyl peptidase 4 (DPP4) was most significantly associated with clinical aggressiveness of UCs. Quantitative RT-PCR confirmed upregulation of DPP4 mRNA in advanced stage UCs. The clinical significance of DPP4 expression was validated in our large cohort consists of 635 UCs from upper urinary tract and urinary bladder. Univariate and multivariate analyses show that DPP4 is an independent prognosticatory biomarker for disease-specific survival and metastasis-free survival. Comparing the DPP4 expression level of three urothelial cell lines with normal urothelial cells, J82 and RTCC-1 showed a significantly increased in transcript and protein expression. DPP4 knockdown as conducted by using short-hairpin RNA resulted in a significantly decreased cell viability, proliferation, migration, and invasion in J82 and RTCC-1 cells. These findings implicate that DPP4 plays a role in the aggressiveness of UCs, and can serve as a novel prognostic marker and therapeutic target.

KW - DPP4

KW - Overexpression

KW - Proteolysis

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85009733734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009733734&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.13820

DO - 10.18632/oncotarget.13820

M3 - Article

VL - 8

SP - 2995

EP - 3008

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 2

ER -